enVVeno Medical (NVNO) Equity Average (2018 - 2020)

enVVeno Medical has reported Equity Average over the past 3 years, most recently at $5.9 million for Q4 2020.

  • For Q4 2020, Equity Average rose 191.93% year-over-year to $5.9 million; the TTM value through Dec 2020 reached $5.9 million, up 191.93%, while the annual FY2020 figure was $4.0 million, 167.25% up from the prior year.
  • Equity Average for Q4 2020 was $5.9 million at enVVeno Medical, up from $2.6 million in the prior quarter.
  • Over five years, Equity Average peaked at $5.9 million in Q4 2020 and troughed at -$13.4 million in Q1 2018.
  • A 3-year average of $764458.0 and a median of $2.5 million in 2019 define the central range for Equity Average.
  • On a YoY basis, Equity Average climbed as much as 191.93% in 2020 and fell as far as 95.28% in 2020.
  • Year by year, Equity Average stood at $2.8 million in 2018, then dropped by 26.98% to $2.0 million in 2019, then soared by 191.93% to $5.9 million in 2020.
  • Business Quant data shows Equity Average for NVNO at $5.9 million in Q4 2020, $2.6 million in Q3 2020, and $177411.5 in Q2 2020.